Bullfrog AI Holdings, Inc. Common Stock

Bullfrog AI Holdings, Inc. Common Stock Aktien

2,89
-1,20%
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland. Læs mere
$ 23,1M Markedsværdi (Mcap)
$ 65,0K Omsætning
Health Information Services Industri
USA Handles på børsen
bullfrogai.com Hjemmeside
Sundhed Sektor